MFS Meridian Funds - Continental European Equity Fund I1 EURRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | - | - | -4.9 | 11.3 | 3.9 | |
+/-Cat | - | - | 3.9 | -2.2 | 1.4 | |
+/-B’mrk | - | - | 2.6 | -3.6 | -0.6 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 22/11/2024 | EUR 140.21 | |
Day Change | 0.85% | |
Morningstar Category™ | Europe ex-UK Equity | |
ISIN | LU2274088041 | |
Fund Size (Mil) 22/11/2024 | EUR 68.91 | |
Share Class Size (Mil) 22/11/2024 | EUR 0.07 | |
Max Initial Charge | - | |
Ongoing Charge 16/02/2024 | 0.75% |
Investment Objective: MFS Meridian Funds - Continental European Equity Fund I1 EUR |
The Fund’s objective is capital appreciation, measured in euros. The Fund invests primarily (at least 70%) in continental European equity securities. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Matthew Barrett 03/01/2009 | ||
Inception Date 13/01/2021 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
MSCI Europe Ex UK NR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for MFS Meridian Funds - Continental European Equity Fund I1 EUR | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
SAP SE | Technology | 6.26 |
Schneider Electric SE | Industrials | 5.59 |
Roche Holding AG | Healthcare | 5.27 |
Linde PLC | Basic Materials | 4.84 |
Novartis AG Registered Shares | Healthcare | 4.74 |
Increase Decrease New since last portfolio | ||
MFS Meridian Funds - Continental European Equity Fund I1 EUR |